Hereditary Cancer Panels: Know Your Inherited Risk
Who it’s for
These panels may be worth considering if you have a personal or family history of cancer, a known familial gene change, or a background linked to higher inherited risk. A genetic result changes your estimated risk — it does not mean you will, or will not, develop cancer. We recommend discussing testing and results with a genetic counsellor or your doctor.
What you’ll learn
• The balance of bacteria in your vaginal microbiome, including levels of protective Lactobacillus
• Whether your flora looks balanced or disrupted, and your vaginal pH
• Personalised, science-based suggestions to support your intimate wellbeing
How it works
Hereditary Breast Cancer — 11 genes — £499
Hereditary Breast & Ovarian — 16 genes — £499 Hereditary Prostate Cancer — 10 genes — £499 Hereditary Colorectal (Lynch) — 17 genes — £499 Hereditary Melanoma — 7 genes —£499
Hereditary Pancreatic Cancer — 13 genes — £499 Comprehensive Hereditary Cancer — 35 genes — £549
What it covers: analysed by Nonacus, a UK genomic laboratory (ISO 15189:2022 accredited, with a UKAS-accredited report). The Comprehensive Hereditary Cancer Panel analyses carefully curated genes across the most common hereditary cancers — breast, ovarian, colorectal (Lynch syndrome), prostate, pancreatic and melanoma — including BRCA1, BRCA2, the Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2, EPCAM), PALB2, ATM and TP53. Your test includes support from a qualified genetic counsellor before and after testing.
1. Order online — kit dispatched within about 2 working days.
2. Provide your saliva sample.
3. Post to the lab in the prepaid packaging.
4. Get your personalised results securely within 10–14 days.
Understand your inherited cancer risk
Our hereditary cancer panels look for inherited gene changes associated with a higher risk of certain cancers
Our hereditary cancer panels look for inherited gene changes associated with a higher risk of certain cancers, to help you and your clinicians make informed decisions about monitoring and prevention. Choose a panel focused on a specific cancer, or the Comprehensive panel covering the full range. • Simple saliva sample • Analysed by an accredited UK genomic laboratory (Nonacus) • Includes support from a qualified genetic counsellor, before and after testing • Cancer-specific panels from £499 • Comprehensive 35-gene panel £549
Q: Will this tell me if I have cancer?
A: No — it assesses inherited risk, not current disease.
Q: Is there counselling?
A: Yes, a qualified genetic counsellor supports you before and after testing.
Q: Which panel should I choose?
A: A cancer-specific panel if you have a particular family history, or the Comprehensive panel for the full range — your genetic counsellor can help you decide.
Q: How much does it cost and how fast are results?
A: Cancer-specific panels £499; Comprehensive £549; results within 14 working days of the lab receiving your sample (kit dispatched within about 2 working days).
Services We Provide
_jfif.jpg)
Nonacus Clinical Services (UK Partner)
Specialism:
Genomics & Hereditary Cancer
Description:
Birmingham-based specialist genomics laboratory operating as Informed Genomics Limited, trading as Nonacus Clinical Services. Nonacus provides MeCheck’s hereditary cancer panel testing, bladder cancer (GALEAS®) liquid biopsy analysis, and molecular genomics services.
Accreditations:
-
UKAS ISO 15189:2022
-
Schedule No. 22262
-
ISO 27001 Data Security
-
GDPR Compliant
-
ACMG / ACGS Variant Guidelines
Footnote:
Accreditation issued by the United Kingdom Accreditation Service (UKAS) — the sole national accreditation body recognised by the British Government. Accreditation assessed annually.
.png)
Biovis Diagnostik MVZ GmbH (Germany Partner)
Specialism:
Bowel Cancer Screening
Description:
Specialist medical laboratory based in Limburg-Eschhofen, Germany, with over a decade of expertise in stool diagnostics, microbiome analysis, and cancer screening. Biovis provides MeCheck’s bowel cancer (ColoAlert®) testing services.
Accreditations:
-
DAkkS ISO 15189:2024
-
DIN EN ISO 15189
-
Stool Diagnostics Specialist
-
EQA Scheme Participant
Footnote:
Accreditation issued by Deutsche Akkreditierungsstelle (DAkkS) — Germany’s national accreditation body, operating under EU Regulation 765/2008. Equivalent in standing to UKAS accreditation in the UK.
_edited.png)
Bloodo / LifeLab1 (Lithuania Partner)
Specialism:
NAD, NMN & Cellular Wellness
Description:
Bloodo is a Vilnius-based clinical diagnostics company operating LifeLab1, a fully licensed clinical laboratory specialising in dried blood spot (DBS) testing, liquid chromatography/mass spectrometry (LC/MS), and advanced metabolic biomarker analysis. Bloodo provides MeCheck’s NAD and NMN cellular wellness testing services.
LifeLab1 maintains quality standards aligned with ISO 15189 and participates in international external quality assurance (EQA) programmes to ensure consistent, reliable results. The laboratory team comprises experienced medical biologists, quality specialists, PhD candidates, and doctors of pharmacy. Collaborative research is conducted with Vilnius University (Lithuania) and Malmö University (Sweden).
Licences and standards:
-
ISO 15189 Aligned
-
CE Marked · IVDR 2017/746
-
EN ISO 13485 Manufacturing
-
LHP-2819 Licensed
-
NR-4864 State Accredited
-
NM-334 Licensed
Footnote:
Regulated by Lithuanian state health authorities and the Lithuanian National Accreditation Bureau (LA) — a full ILAC MRA signatory and member of the European Accreditation (EA) network.
Additional standards
CE / IVDR — Clinically Validated Test Kits:
All test kits supplied by MeCheck carry CE marking under the EU In Vitro Diagnostic Regulation (IVDR), confirming they meet rigorous safety, performance, and clinical validity requirements before reaching consumers.
Clinical Review — Medically Reviewed Results:
All products are assessed for clinical appropriateness by Dr Tang before listing. Results are benchmarked against current clinical reference ranges and provided with clear, actionable guidance.